Insulin Prices, College Cancellation Fear, Stock Buybacks

Insulin Prices [01:43]

How Much Does Insulin Cost? Here’s How 28 Brands and Generics Compare (GoodRx, 1/26/22)
Analysis: Eli Lilly is capping insulin copays at $35. Here are 5 questions answered (PBS/The Conversation, 3/5/23)
Eli Lilly to Cut Prices of Insulin Drugs by 70%, Cap Patient Costs at $35 (Wall Street Journal, 3/1/23)
How the New $35 Cap on Insulin Costs Will Work (Wall Street Journal, 1/11/23)
Why Insulin Is So Expensive and How California Aims to Produce Its Own | WSJ (YouTube/Wall Street Journal, 8/17/22)
Let’s not mistake Eli Lilly’s insulin cap for altruism (MSNBC, 3/2/23)
The Insulin Pricing Wars Are Just Getting Started (The New Republic, 3/3/23)
Joe Biden’s Insulin Fictions (WSJ Editorial Board, 3/2/23)
The Last Thing Insulin Markets Need Is More Government (National Review, 8/10/22)
The Foolishness of Prescription-Drug Price Controls (National Review, 11/27/21)
Are pharmacy benefit managers the good guys or bad guys of drug pricing? (STAT News, 8/27/18)
Insulin prices are skyrocketing, but just who is driving the rise in costs? Hint: it’s not the drug manufacturers (USC, 8/26/22)
In health care, America is the world’s indispensable nation (Washington Post, 11/29/22)
America is subsidizing Europe’s socialist medicine — with higher drug prices here (The Hill, 12/8/20)
The global burden of medical innovation (Brookings, 1/30/18)
Debunking The Pharmaceutical Research ‘Free Rider’ Myth: A response To Yu, Helms, And Bach (Health Affairs, 6/2/17)

College Cancellation Fear [24:13]

More than half of college professors bite their tongues over cancel culture fears (New York Post, 2/28)
The Academic Mind in 2022: What Faculty Think About Free Expression and Academic Freedom on Campus (FIRE, 2023)

Stock Buybacks [37:28]

Why investors like Warren Buffett are so fond of stock buybacks (Axios, 2/7/23)
Warren Buffett calls stock buyback critics ‘economic illiterate’ in Berkshire Hathaway annual letter (CNBC, 2/25/23)
Stop Demonizing Stock Buybacks (The Atlantic, 2/17/23)
Biden’s 1% stock buyback tax isn’t working. Will asking Congress to raise it do any good? (CNBC, 2/7/23)
Stock Buybacks and Dividends Become a $1.5 Trillion Political Target (New York Times, 8/13/22)
Stock Buybacks Race to Record $132 Billion Start as Companies Snub All Warnings (Bloomberg, 2/2/23)
3 myths underlying Biden’s proposed increase in tax on stock buybacks (The Hill, 2/28/23)
Biden and Schumer lead nonsensical progressive charge against stock buybacks (Washington Post, 3/3/23)
Stock Buybacks Aren’t Bad. They Aren’t Good, Either. (Wall Street Journal, 2/17/23)
Stock Buybacks Help No One in the Long Term | Opinion (NewsWeek, 3/1/23)
Are Stock Buybacks A Good Thing? Not Always (The Street, 2/28/23)
What Is A Stock Buyback? (Forbes, 2/7/23)
Berkshire Hathaway Inc. 2022 Annual Report (Berkshire Hathaway, 2/25/23)
Market underreaction to open market share repurchases (Journal of Financial Economics, 11/95)
Payout policy in the 21st century (Journal of Financial Economics, 9/05)
The Price Effect of Stock Repurchases: Evidence from Dual Class Firms (Management Science, 6/26/21)
Stock Buybacks: Is Excess Cash Being Spent Wisely? (J.P. Morgan, 8/15/19)

Voicemail [50:00]